Literature DB >> 25674864

FDG and (82)Rb PET/MRI features of brain metastasis of breast cancer.

Yang Lu1.   

Abstract

A 64-year-old woman with stage IV breast cancer underwent an FDG and Rb PET brain studies. The PET brain images were fused with MRI brain T1 post-contrast images. The known enhancing left superoposterior frontal brain metastasis is positive on both FDG Rb PET/MRI images. The Rb PET/MRI showed better target-to-noise ratio, but showed nonspecific uptake in the superior sagittal sinus.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25674864     DOI： 10.1097/RLU.0000000000000712

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  7 in total

1.  PET imaging in patients with brain metastasis-report of the RANO/PET group.

Authors:  Norbert Galldiks; Karl-Josef Langen; Nathalie L Albert; Marc Chamberlain; Riccardo Soffietti; Michelle M Kim; Ian Law; Emilie Le Rhun; Susan Chang; Julian Schwarting; Stephanie E Combs; Matthias Preusser; Peter Forsyth; Whitney Pope; Michael Weller; Jörg C Tonn
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

2.  Renal Potassium Excretion Visualized on 82Rubidium PET/CT.

Authors:  Mads Ryø Jochumsen; Lars Poulsen Tolbod; Michael Borre; Jørgen Frøkiær; Kirsten Bouchelouche; Jens Sörensen
Journal:  Nucl Med Mol Imaging       Date:  2020-04-15

Review 3.  Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis.

Authors:  Synnøve Nymark Aasen; Heidi Espedal; Olivier Keunen; Tom Christian Holm Adamsen; Rolf Bjerkvig; Frits Thorsen
Journal:  Neurooncol Adv       Date:  2021-10-14

4.  Rubidium Uptake in Chest Tumors on PET/CT.

Authors:  Jorge D Oldan; Abiola D Femi-Abodunde; Mitchel A Muhleman; Amir H Khandani
Journal:  World J Nucl Med       Date:  2022-02-24

5.  82Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis.

Authors:  Ephraim E Parent; Ila Sethi; Jonathon Nye; Chad Holder; Jeffrey J Olson; Jeffrey Switchenko; Funmilayo Tade; Oladunni O Akin-Akintayo; Olayinka A Abiodun-Ojo; Akinyemi Akintayo; David M Schuster
Journal:  Q J Nucl Med Mol Imaging       Date:  2019-12-09       Impact factor: 2.346

Review 6.  PET Metabolic Biomarkers for Cancer.

Authors:  Etienne Croteau; Jennifer M Renaud; Marie Anne Richard; Terrence D Ruddy; François Bénard; Robert A deKemp
Journal:  Biomark Cancer       Date:  2016-09-20

7.  Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na+/K+-ATPase-density.

Authors:  Mads Ryø Jochumsen; Jens Sörensen; Bodil Ginnerup Pedersen; Jens Randel Nyengaard; Søren Rasmus Palmelund Krag; Jørgen Frøkiær; Michael Borre; Kirsten Bouchelouche; Lars Poulsen Tolbod
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-08-18       Impact factor: 9.236
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.